Abstract
We evaluated cells from 24 patients with B cell chronic lymphocytic leukemia (B-CLL) to determine apoptosis induced by CD5 hypercross-linking. Following the CD5 hypercross-linking with anti-CD5 monoclonal antibodies (MoAbs), we identified 10 patients where CD5 hypercross-linking induced apoptosis (group A) and 14 patients whose cells were resistant to the anti-CD5 MoAbs (group B). The programmed cell death pathway of the cells from patient group A was caspase-3 and poly (ADP-ribose) polymerase (PARP)-dependent, involved a reduction of the mitochondrial transmembrane potential ΔΨ and a down-regulation of the anti-apoptotic Bcl-2, Mcl-1 and iNOS proteins. Early activation-associated molecules such as CD25 and CD69 were expressed at higher levels than in controls after 6 h of culture with anti-CD5 MoAb. The expression of CD5 and of CD72, the ligand for CD5, were significantly lower in group A compared with group B. Anti-CD20 MoAb had similar activity with anti-CD5 MoAb and the combination of the two MoAbs seemed to be additive. In this study, it is suggested that the cells from some B-CLL patients can be induced into programmed cell death by CD5 hypercross-linking with anti-CD5 MoAbs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout





Similar content being viewed by others
References
Reed JC . Molecular biology of chronic lymphocytic leukemia Semin Oncol 1998 25: 11–18
Gottardi D, Alfarano A, De Leo M, Stacchini A, Aragno M, Rigo A, Veneri D, Zanotti R, Pizzolo G, Caligaris-Cappio F . In leukaemic CD5+ B cells the expression of Bcl-2 gene family is shifted toward protection from apoptosis Br J Haematol 1996 94: 612–618
Klein A, Miera O, Bauer O, Golfier S, Schriever F . Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair Leukemia 2000 14: 40–46
Tangye SG, Raison RL . Human cytokines supress apoptosis of leukaemic CD5+ cells and preserve expression of bcl-2 Immunol Cell Biol 1997 75: 127–135
Molica S, Vitelli G, Levato D, Levato L, Datillo A, Gandolfo GM . Clinico–biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia Haematology 1999 84: 208–211
Plate JM, Long BW, Kelkar SB . Role of beta2 integrins in the prevention of apoptosis induction in chronic lymphocytic leukemia B cells Leukemia 2000 14: 34–39
Mainou-Fowler T, Prentice AG . Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukemia Leuk Lymphoma 1996 21: 369–377
Laytragoon-Lewin N, Duhony E, Bai XF, Mellstedt H . Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells Eur J Haematol 1998 61: 266–271
Kneitz C, Goller M, Wilhelm M, Mehringer C, Wohlleben G, Schimpl A, Tony HP . Inhibition of T cell/B cell interaction by B-CLL cells Leukemia 1999 13: 98–104
Multani PS, Grossbard ML . Monoclonal antibody-based therapies for hematologic malignancies J Clin Oncol 1998 16: 3691–3710
Meeker TC, Lowder J, Maloney DG, Miller R, Thielelmans K, Warnke R, Levy R . A clinical trial of anti-idiotype therapy for B cell malignancy Blood 1985 73: 1349–1363
McLaughlin P, White CA, Grillo-Lopez AJ . Clinical status and optimal use of Rituximab for B-cell lymphomas Oncology 1998 12: 1769–1777
Nguyen DT, Amess JA, Doughty H, Hendry L, Diamond LW . IDEC-C2B8 anti-CD20 (rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders: evaluation of response on 48 patients Eur J Haematol 1999 62: 76–82
Osterborg A, Fassas AS, Anagnostopoulos A, Dyer MS, Catovsky D, Mellstedt H . Humanized CD52 monoclonal antibody Campath-1H as first-line treatment in chronic lymphocytic leukemia Br J Haematol 1996 93: 151–153
Boumsell L, Bernard A, Lepage V, Degos L, Lemerle J, Dausset J . Some chronic lymphocytic leukemia cell bearing surface immunoglobulins share determinants with T cells Eur J Immunol 1978 8: 900–904
Caligaris-Cappio F, Gobbi M, Bofill M, Janossy G . Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia J Exp Med 1982 155: 623–628
Kantor AB, Herzenberg LA . Origin of murine B cell lineages Annu Rev Immunol 1993 11: 501–539
Pers J-O, Jamin C, Le Corre R, Lydyard PM, Youinou P . Ligation of CD5 on resting B cells, but not on resting T cells, results in apoptosis Eur J Immunol 1998 28: 4170–4176
Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternak BS . Clinical staging of chronic lymphocytic leukemia Blood 1975 46: 219–234
Chaouchi N, Vazquez A, Galanaud P, Leprince C . B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking J Immunol 1995 54: 3096–3104
Shan D, Ledbetter JA, Press OW . Apoptosis of malignant B cells by ligation of CD20 with monoclonal antibodies Blood 1998 91: 1644–1652
Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JC, Petit PX, Kroemer G . Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo J Exp Med 1995 181: 1661–1672
Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG . Specific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis Cancer Res 1993 53: 3976–3985
Yang E, Korsmeyer SJ . Molecular thanatopsis: a discourse on the BCL2 family and cell death Blood 1996 88: 386–401
Zhao H, Dugas N, Mathiot C, Delmer A, Dugas B, Sigaux F, Kolb J-P . B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity Blood 1998 92: 1031–1043
Kolb JP . Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia Leukemia 2000 14: 1685–1694
Roman V, Zhao H, Fourneau JM, Marconi A, Dugas N, Dugas B, Sigaux F, Kolb JP . Expression of a functional inducible nitric oxide synthase in hairy cell leukaemia and ESKOL cell line Leukemia 2000 14: 696–705
Cantor GH, Pritchard SM, Dequiedt F, Willems L, Kettmann R, Davis WC . CD5 is dissociated from the B-cell receptor in B cells from bovine leukemia virus-infected, persistently lymphocytotic cattle: consequences to B-cell receptor-mediated apoptosis J Virol 2001 75: 1689–1696
Verwilghen J, Vandesande R, Vandenberghe P, Ceuppens JL . Crosslinking of the CD5 antigen on human T cells induces functional IL2 receptors Cell Immunol 1990 131: 109–119
Vandenberghe P, Verwilghen J, Van Vaeck F, Ceuppens JL . Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism Immunology 1993 78: 210–217
Cerutti A, Trentin L, Zambello R, Sancetta R, Milani A, Tassinari C, Adami F, Agostini C, Semenzato G . The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity J Immunol 1996 157: 1854–1862
Ashwell JD, Longo DL, Bridges SH . T-cell tumor elimination as a result of T-cell receptor-mediated activation Science 1987 237: 61–64
Ucker DS, Meyers J, Obermiller PS . Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death J Immunol 1992 149: 1583–1592
Radvanyi LG, Mills GB, Miller RG . Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death J Immunol 1993 150: 5704–5715
Daniel PT, Oettinger U, Mapara MY, Bommert K, Bargou R, Dorken B . Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function Eur J Immunol 1997 27: 1029–1034
Parry SL, Hasbold J, Holman M, Klaus GGB . Hypercrosslinking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40 J Immunol 1994 152: 2821–2829
Gibson J, Neville S, Joshua D, Kronenberg H . CD23 expression in CLL Br J Haematol 1989 72: 598
Barnett D, Reilly JT . Lack of corelation between cell surface activation antigen expression and clinical stage in CLL Br J Haematol 1989 73: 572
Peng B, Raveche E . Apoptosis induction in CD5+ (Ly1+) malignant B cells Leukemia 1993 7: 789–794
Van de Velde H, von Koegen I, Luo W, Parnes JR, Thielemans K . The B-cell surface protein CD72/Lyb-2 is the ligand for CD5 Nature 1991 351: 662–665
Jamin C, Le Corre R, Pers JO, Dueymes M, Lydyard PM, Youinou P . Modulation of CD72 by ligation of B cell receptor complex molecules on CD5+ cells Int Immunol 1997 9: 1001–1009
Jamin C, Lamour A, Pennec L, Hirn M, Le Goff P, Youinou P . Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjogren's syndrome Clin Exp Immunol 1993 92: 245–250
Katira A, Kamal M, Gordon J . Occupancy of CD72 (the CD5 counterstructure) enhances interleukin-4-dependent CD23 expression in resting B lymphocytes Immunology 1992 76: 422–426
Pospisil R, Fitts MG, Mage RG . CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences J Exp Med 1996 184: 1279–1284
Lankester AC, van Schijndel GM, Cordell JL, van Noesel CJ, van Lier RA . CD5 is associated with the human B cell antigen receptor complex Eur J Immunol 1994 24: 812–816
Sen G, Bikah G, Venkataraman C, Bondada S . Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells Eur J Immunol 1999 29: 3319–3328
Pospisil R, Mage RG . CD5 and other superantigens as ‘ticklers’ of the B-cell receptor Immunol Today 1998 19: 106–108
Chen W, Wang HG, Srinivasula S, Alnemri ES, Cooper ND . B cell apoptosis triggered by antigen receptor ligation proceeds via a novel caspase-dependent pathway J Immunol 1999 163: 2483–2491
Berard M, Mondiere P, Casamayor-Palleja M, Hennino A, Bella C, Defrance T . Mitochondria connects the antigen receptor to effector caspases during B cell receptor-induced apoptosis in normal human B cells J Immunol 1999 163: 4655–4662
Nomura T, Han H, Howard MC, Yagita H, Yakura H, Honjo T, Tsubata T . Antigen receptor-mediated B cell death is blocked by signaling via CD72 or treatment with dextran sulfate and is defective in autoimmunity-prone mice Int Immunol 1996 8: 867–875
Acknowledgements
We thank Professor Kendo Kiyosawa for valuable advice and Dr Fumihiro Ishida for constructive discussion. We also thank Mr Susumu Ito for technical assistance and Drs Mayumi Ueno, Shigetaka Shimodaira, Shojiro Takagi, Naohiko Chiba, Hiroshi Morishita, Shigeki Seki, Naoaki Ichikawa, Toshiro Ito, Hikaru Kobayashi and Hiroshi Saito for providing patient samples.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cioca, D., Kitano, K. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia. Leukemia 16, 335–343 (2002). https://doi.org/10.1038/sj.leu.2402393
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.leu.2402393
Keywords
This article is cited by
-
Expression of activated molecules on CD5+B lymphocytes in autoimmune hemolytic anemia
International Journal of Hematology (2016)
-
Immunological aspects in chronic lymphocytic leukemia (CLL) development
Annals of Hematology (2012)
-
Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia
Molecular Cancer (2011)


